Submitted by reuters8361 in business
The U.S. Food and Drug Administration (FDA) has approved Ardelyx's <a href="https://www.reuters.com/markets/companies/ARDX.O" target="_blank">(ARDX.O)</a> drug to treat high phosphate levels in patients with chronic kidney disease (CKD), the company said on T…